MELISSA SVOBODA

Concepts (64)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Muscular Atrophy, Spinal
3
2026
47
2.730
Why?
Biological Products
2
2026
145
1.600
Why?
Azetidines
1
2026
64
0.940
Why?
Spinal Muscular Atrophies of Childhood
1
2025
23
0.910
Why?
Troponin I
1
2025
122
0.850
Why?
Genetic Therapy
2
2025
726
0.800
Why?
Azo Compounds
2
2026
12
0.480
Why?
Recombinant Fusion Proteins
2
2026
692
0.390
Why?
Pyrimidines
2
2026
443
0.370
Why?
Drug Substitution
1
2025
24
0.240
Why?
Psychotropic Drugs
1
2025
123
0.220
Why?
Drug Utilization
1
2025
164
0.220
Why?
Antipsychotic Agents
1
2025
379
0.180
Why?
Child, Preschool
4
2026
15047
0.180
Why?
Autism Spectrum Disorder
1
2025
437
0.160
Why?
Treatment Outcome
2
2026
12936
0.150
Why?
Practice Patterns, Physicians'
1
2025
775
0.150
Why?
Child
5
2026
26239
0.140
Why?
Motor Skills Disorders
1
2007
9
0.140
Why?
Communication Disorders
1
2007
9
0.140
Why?
Apraxias
1
2007
16
0.130
Why?
Social Behavior
1
2007
217
0.120
Why?
Multiple Chemical Sensitivity
1
2015
1
0.120
Why?
Hearing Loss, Sensorineural
1
2017
155
0.110
Why?
Cytomegalovirus Infections
1
2017
225
0.110
Why?
Genetic Association Studies
1
2018
838
0.110
Why?
Drug Hypersensitivity
1
2015
97
0.100
Why?
Female
7
2026
71087
0.100
Why?
Infant
3
2025
13300
0.100
Why?
Male
5
2026
65158
0.100
Why?
Humans
8
2026
131504
0.100
Why?
Carrier Proteins
1
2018
1024
0.090
Why?
Attention Deficit Disorder with Hyperactivity
1
2015
238
0.090
Why?
Infant, Newborn
1
2025
8589
0.090
Why?
Mothers
1
2015
371
0.090
Why?
Developmental Disabilities
1
2017
760
0.090
Why?
Autistic Disorder
1
2015
387
0.090
Why?
Retrospective Studies
1
2025
17648
0.060
Why?
Aripiprazole
1
2025
23
0.060
Why?
Risperidone
1
2025
61
0.060
Why?
Mutation
1
2018
6177
0.050
Why?
Young Adult
3
2025
10092
0.040
Why?
Apraxia, Ideomotor
1
2007
1
0.030
Why?
Asperger Syndrome
1
2007
8
0.030
Why?
Adolescent
3
2025
20917
0.030
Why?
Fatal Outcome
1
2018
364
0.030
Why?
Observer Variation
1
2007
319
0.030
Why?
Psychomotor Performance
1
2007
178
0.030
Why?
Gene-Environment Interaction
1
2015
128
0.030
Why?
Health Surveys
1
2015
262
0.030
Why?
Neuropsychological Tests
1
2007
995
0.030
Why?
Cognition Disorders
1
2007
565
0.020
Why?
Mass Screening
1
2007
825
0.020
Why?
Diagnosis, Differential
1
2017
1910
0.020
Why?
Prevalence
1
2007
2692
0.020
Why?
Logistic Models
1
2015
1831
0.020
Why?
Adult
2
2025
31666
0.020
Why?
United States
1
2025
11794
0.020
Why?
Severity of Illness Index
1
2007
3090
0.020
Why?
Case-Control Studies
1
2015
3452
0.020
Why?
Cross-Sectional Studies
1
2015
3834
0.020
Why?
Brain
1
2017
3237
0.010
Why?
Risk Factors
1
2015
10952
0.010
Why?
Middle Aged
1
2015
28839
0.010
Why?
SVOBODA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (64)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_